Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed May 24, 2019
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2019-05-22$6.00/sh−416$2,496→ 10,000 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.